GemPharmatech proudly partnered with Fierce Biotech to bring you our most recent webinar, Moving from Discovery to Clinic with Genetically Engineered Mouse Models. In this compelling webinar Dr. Mark Moore and Dr. Santi Suryani Chen discuss the importance and value of using genetically modified mouse models (GEMMs) to accelerate preclinical research from discovery to the clinic. Specifically, they share information about screening methods and generating safety and efficacy data using conditional knockout mice, humanized immune checkpoint mice, and immunocompromised mouse models.

Please click here to visit Fierce Biotech's website where you can register to watch the webinar on-demand.